1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow FLOT Chemotherapy: new trials by email Literature Review of FLOT Chemotherapy trials Research Report on FLOT Chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd) - Gastroesophageal Adenocarcinoma | Phase 2 | Recruiting | AstraZeneca | 100 | 2025-07-17 | 2026-11-03 |
| Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer FLOT Chemotherapy, SOX Chemotherapy - Gastric Cancer, Chemotherapy Effect | Phase 2 | Completed | Ruijin Hospital | 74 | 2018-08-24 | 2025-07-23 |
AstraZeneca (1) · Ruijin Hospital (1)
China (2) · Canada (1) · Georgia (1) · Italy (1) · Japan (1) · Poland (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Birendra Kumar Sah, PH D (1) · Chen Li, PH D (1) · Zhenggang Zhu, PH D (1)